Tackling the Kokoda Trail for melanoma
6 April 2018
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark “Bod” Boddison.
Fraser’s trek fell in the middle of Melanoma Institute Australia’s major fundraising and awareness campaign Melanoma March which spans across 22 locations around the country, supporting, remembering and fundraising for past and present melanoma patients.
Out of sight, does not mean out of mind for Fraser and Bod. Friends for nearly 40 years, the pair remained very close after Fraser relocated to Australia from Scotland 19 years ago. “We kept in regular contact despite being on the other side of the world. He visited me in Oz on a number of occasions and I took my family to Scotland and we spent our 40th Birthday’s together”.
Bod was diagnosed with melanoma 11 years ago but was given the all clear. Six years later, due to the viciousness of melanoma, Bod had tumours in his brain, abdomen and other parts of his body. But Bod did not lose his sense of humour or positive attitude. Fraser flew to Scotland to spend some time with his lifelong friend. “Those two weeks were priceless for us”, Fraser said.
Devastatingly, Bod lost his battle on March 11th last year. Fraser took on Kokoda just over one year since Bod passed away. Fraser is hoping to fundraise and raise awareness about melanoma. Even though Scotland doesn’t cop the brunt of extreme UV rays like Australia, melanoma doesn’t discriminate.
Bod left behind his wife Ailsa and daughter Zoe who I keep in regular contact with and they are coping as well as can be expected. I also speak regularly to Bod's parents whom I have known since I was a little schoolboy & I find it very difficult speaking to them as I can hear just how terribly sad they are without Mark.
With three young children who spend a lot of time playing outside, Fraser is patently aware of the dangers of too much sun. “I was shocked to read the statistics regarding young Aussies and melanoma so that fortified my decision to raise funds”, Fraser said.
Fraser braved harsh terrain and difficult trekking conditions including extreme humidity and wet conditions. Fraser took on an incredible challenge for Melanoma Institute Australia and you can help him take it one step further by donating to his cause here.
Can an individual’s risk factors for melanoma be used to tailor skin self-examinations and surveillance programs?
Prof Georgina Long has been appointed President-Elect Society for Melanoma Research (SMR).
The Australasian Melanoma Conference is bringing together some of the world's leading researchers and clinicians.
Best practice guidelines for melanoma care have gone digital with the first-ever online guidelines developed to adapt to the rapid change in clinical management.
Congratulations are in order for two of our talented researchers.
Professor Richard Scolyer will be sharing his expertise on melanoma pathology at the upcoming Australasian Melanoma Conference. Here he discusses what he'll be presenting on.
Researchers at MIA have established a High Risk Clinic to monitor people at very high risk of developing melanoma.
A generous donation has enabled a medical oncologist from Portugal to learn from the best in the world at MIA.
MIA is hosting a conference to bring together greats minds in melanoma research that will make a difference to the lives of melanoma patients
Meet Michelle, our Translational Research Officer whose role is to connect the clinics to the lab by ensuring patient blood and tissue samples are documented and carefully stored in our BioSpecimen Bank.
Dr James Wilmott says his Wildfire Award will help expand research into treatment options for people with mucosal melanoma, a rare but deadly form of skin cancer.
Following the recent hype around immunotherapies in cancer, CEO Carole Renouf shares the greatest story never told… resistance… and what MIA is doing to address it.
A/Prof Wargo discusses the research she will be presenting as a keynote speaker at the upcoming Australasian Melanoma Conference.
Dr James Wilmott has been awarded the Wildfire award at this year's Cancer Institute NSW's Premier Awards for Outstanding Cancer Research.
The community has responded generously to our recent appeal to fund a specialised nursing position in an exciting new clinical trial.
We have developed a unique clinical trial that will use existing drugs to target rare genes in melanoma patients.
Data presented at the recent ASCO Annual Meeting showcased advances in melanoma research, particularly long-term survival data.
We value your privacy and want you to be familiar with how we collect, use and disclose your information.
Melanoma Institute Australia has partnered with IBM Research in Australia to help further advance melanoma identification using cognitive technology.
CEO Carole Renouf chats to senior clinicians and researchers as part of our "4 Questions With..." short video series.